CD4 and cancer: The proportion of major cells that participate in cancer cell killing and tumor elimination, including CD4+ T cells, CD8+ T cells, mature B cells, monocytes and dendritic cells, were lower in the MO-MLPS high risk LUAD patients than those with the MO-MLPS low risk.